Summary & Overview
CPT 1066F: Clinical Performance Measure
CPT code 1066F is a CPT-designated measure entry for clinical documentation; no descriptive summary text was available in the source input. As a CPT measure code, 1066F is used within clinical reporting and administrative workflows to capture a specific performance or quality element tied to patient care. Nationally, CPT measure codes support quality reporting, payer adjudication, and population-level performance assessment, making accurate coding important for interoperability and claims processing.
Key payers discussed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise orientation to the code’s purpose, an explanation of expected service context where available, and notes on what data elements are present or missing. The publication outlines benchmarking and policy-relevant interpretation where applicable, highlights typical stakeholder considerations for CPT measure codes, and identifies gaps in the input data that limit detailed clinical or billing guidance.
This summary is written for a national audience and frames 1066F as a CPT measure code used in quality and administrative reporting rather than a discrete procedural service. Data not provided in the input is noted explicitly in the detailed sections of the publication.
Billing Code Overview
CPT code 1066F has no summary available in the source description. Based on the code label provided, this entry represents a clinical performance measure in the CPT coding framework. Service type: Data not available in the input. Typical site of service: Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an outpatient dermatology or primary care visit for assessment and management of a small, benign-appearing skin lesion (for example, a common wart, skin tag, or actinic keratosis) requiring a limited, focused procedure such as bedside cryotherapy, topical chemical destruction, or a single small lesion debridement. The patient is a generally healthy adult who presents with a single symptomatic lesion causing pain, bleeding, or cosmetic concern. The clinical workflow includes history and focused skin examination, informed consent for a minor procedure, application of local anesthetic if indicated, performance of the targeted destructive or removal technique, immediate post-procedure wound care instructions, and brief documentation of lesion size, method used, and patient tolerance. Typical site of service is an outpatient clinic, dermatology office, or primary care office procedure room. Typical service type is a minor office-based dermatologic procedure.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service on same day | Use when a distinct E/M visit is documented in addition to the procedure |
50 | Bilateral procedure |